Figures & data
![](/cms/asset/9bfef77f-3b2b-4424-9685-7c8cfff9c76a/djaa_a_12166880_uf0001_b.jpg)
Table 1 Patient Baseline Demographics and Clinical Characteristics
Figure 1 Rate ratios for clinically significant exacerbations by atopy/baseline blood eosinophil count status. Atopy was defined according to sensitization to any one of the following allergens: A. alternata, cockroach, HDM, cat dander and dog dander. Non-atopic: class 0 (IgE <0.35 kU/L); atopic: classes 1, 2 and 3 (IgE β₯0.35β17.5 kU/L); strongly atopic: classes 4, 5 and 6 (IgE >17.5 kU/L).
![Figure 1 Rate ratios for clinically significant exacerbations by atopy/baseline blood eosinophil count status. Atopy was defined according to sensitization to any one of the following allergens: A. alternata, cockroach, HDM, cat dander and dog dander. Non-atopic: class 0 (IgE <0.35 kU/L); atopic: classes 1, 2 and 3 (IgE β₯0.35β17.5 kU/L); strongly atopic: classes 4, 5 and 6 (IgE >17.5 kU/L).](/cms/asset/22ba0295-c24c-4732-9c85-a366c65cc95d/djaa_a_12166880_f0001_c.jpg)
Figure 2 Rate ratios for clinically significant exacerbations by HDM sensitivity. HDM-sensitive (classes 1β6: IgE β₯0.35 kU/L to D. farinae and/or D. pteronyssinus) or HDM non-sensitive (class 0: IgE <0.35 kU/L to D. farinae and/or D. pteronyssinus). Within these categories, patients were grouped according to sensitivity to other allergens (A. alternata, cockroach, cat dander or dog dander; classes 1β6: β₯0.35 kU/L) to β₯1, β₯2 or β₯3 additional allergens.
![Figure 2 Rate ratios for clinically significant exacerbations by HDM sensitivity. HDM-sensitive (classes 1β6: IgE β₯0.35 kU/L to D. farinae and/or D. pteronyssinus) or HDM non-sensitive (class 0: IgE <0.35 kU/L to D. farinae and/or D. pteronyssinus). Within these categories, patients were grouped according to sensitivity to other allergens (A. alternata, cockroach, cat dander or dog dander; classes 1β6: β₯0.35 kU/L) to β₯1, β₯2 or β₯3 additional allergens.](/cms/asset/6c84cbb0-1ae1-4b67-824f-7e864e498c0e/djaa_a_12166880_f0002_c.jpg)
Figure 3 Change from baseline in ACQ-5 score at Week 32 by atopy and baseline blood eosinophil count categories. Atopy was defined according to sensitization to any one of the following allergens: A. alternata, cockroach, HDM, cat dander and dog dander. Non-atopic: class 0 (IgE <0.35 kU/L; atopic: classes 1, 2 and 3 (IgE 0.35β17.5 kU/L); strongly atopic: classes 4, 5 and 6 (IgE 17.6β>100 kU/L).
![Figure 3 Change from baseline in ACQ-5 score at Week 32 by atopy and baseline blood eosinophil count categories. Atopy was defined according to sensitization to any one of the following allergens: A. alternata, cockroach, HDM, cat dander and dog dander. Non-atopic: class 0 (IgE <0.35 kU/L; atopic: classes 1, 2 and 3 (IgE 0.35β17.5 kU/L); strongly atopic: classes 4, 5 and 6 (IgE 17.6β>100 kU/L).](/cms/asset/79a39c08-2656-4993-88e3-2a69ee18ae33/djaa_a_12166880_f0003_c.jpg)
Figure 4 Change from baseline in ACQ-5 score at Week 32 by HDM sensitivity. HDM-sensitive (classes 1β6: IgE β₯0.35 kU/L to D. farinae and/or D. pteronyssinus) or HDM non-sensitive (class 0: IgE <0.35 kU/L to D. farinae and/or D. pteronyssinus). Within these categories, patients were grouped according to HDM sensitivity (classes 1β6: β₯0.35 kU/L) and to additional allergens (ie β₯1, β₯2 or β₯3 additional allergens; A. alternata, cockroach, cat dander or dog dander).
![Figure 4 Change from baseline in ACQ-5 score at Week 32 by HDM sensitivity. HDM-sensitive (classes 1β6: IgE β₯0.35 kU/L to D. farinae and/or D. pteronyssinus) or HDM non-sensitive (class 0: IgE <0.35 kU/L to D. farinae and/or D. pteronyssinus). Within these categories, patients were grouped according to HDM sensitivity (classes 1β6: β₯0.35 kU/L) and to additional allergens (ie β₯1, β₯2 or β₯3 additional allergens; A. alternata, cockroach, cat dander or dog dander).](/cms/asset/dcce0dc9-118d-4d9d-9e1a-d314ad5cc2ab/djaa_a_12166880_f0004_c.jpg)